Quick Reference
| Property |
Peptides as Research Tools |
| Definition |
Short chains of amino acids (typically <50 residues) |
| Bond type |
Peptide bonds (covalent amide bonds) |
| Major classes |
Receptor agonists, enzyme substrates/inhibitors, hormones, antimicrobials |
| Common modifications |
Acetylation, amidation, cyclization, lipidation, PEGylation |
| Synthesis method |
Solid-phase peptide synthesis (Merrifield method) |
| Typical purity |
≥95% (research grade), ≥98% (premium) |
| Stability |
Lyophilized form preferred; reconstitute for use |
| Quality documentation |
Certificate of Analysis (COA) with each lot |
At a glance:
- One of the most important molecular tool classes in biological research
- Span dipeptides (2 aa) to polypeptides (~50 aa)
- Used as receptor agonists, enzyme tools, hormones, signaling molecules
- Solid-phase synthesis enables precise sequence control
- Quality documentation supports rigorous research
Peptides have become one of the most important molecular tool classes in modern biological research. From the first isolation of insulin in the 1920s to the latest cyclic peptide drug discovery campaigns, short chains of amino acids have shaped how researchers ask questions about cell signaling, tissue repair, metabolism, immunity, and a long list of other biological processes. This comprehensive guide is an overview of peptide science as it applies to preclinical research. It covers what peptides are, how they are made, how they are classified, how they are delivered in animal models, what they are used for, and where the field is going. It is meant to be a starting point for researchers who are new to peptides, and a useful reference for researchers who already work with them.
Midwest Peptide supplies research peptides for in vitro and preclinical use. Every product on our catalog is intended strictly for research applications and is accompanied by a third-party certificate of analysis. This guide does not describe human use, dosing, or any therapeutic application. Where the literature touches on clinical research, it is clearly noted as published clinical research and is not a recommendation.
This pillar article is part of a topic cluster. The four supporting articles linked at the end go deeper into peptide structure and synthesis, peptide classification, peptide delivery routes, and peptide research applications.
Related research: Peptide Modifications Research: PEGylation, Lipidation, and Cyclization in Preclinical Studies.
What is a peptide?
A peptide is a short chain of amino acids linked together by covalent bonds called peptide bonds. Each amino acid contributes a side chain with its own chemical character, and the linear order of those side chains determines the chemistry, the shape, and the biological activity of the resulting molecule. By scientific convention, chains shorter than about fifty amino acids are described as peptides, while longer chains are described as proteins. The boundary is not perfectly sharp and the language used in the literature varies, but the convention is widely used in biochemistry and pharmacology.
A dipeptide has two amino acids. A tripeptide has three. An oligopeptide has up to about ten or twenty residues, and a polypeptide can extend up to the protein boundary. Many of the peptides studied as research tools fall in the range of three to about forty residues. GHK-Cu is a tripeptide of glycine, histidine, and lysine coordinated to a copper ion. BPC-157 is a pentadecapeptide of fifteen amino acids. Selank is a heptapeptide of seven amino acids. The longer peptides studied in research, such as Tesamorelin, can reach forty four residues or more.
Peptides are not only molecules of biological importance. They are also useful chemical tools because their structure can be controlled with high precision. A researcher who wants to study a particular receptor, a particular enzyme, or a particular signaling pathway can often design or order a peptide that interacts with that target in a defined way. This precision is one of the main reasons peptides have become so widely used in preclinical research, alongside small molecules and recombinant proteins.
Authoritative scientific publishers maintain large topic hubs that summarize the field. The Nature subject hub on peptides and the ScienceDirect topic page for peptide are two starting points for researchers who want to read primary literature on the topics discussed in this guide.
Related research: Where to Buy Research Peptides: A Researcher's Sourcing Guide.
A brief history of peptide research
The story of peptide research is tightly linked to the story of biochemistry itself. In the early twentieth century, biochemists were just beginning to understand that proteins were made of amino acids and that these amino acids were strung together in defined sequences. The discovery of insulin by Banting, Best, Macleod, and Collip at the University of Toronto in the early 1920s was a turning point. Insulin was the first peptide hormone to be isolated, characterized, and used for research and clinical purposes. It is technically a small protein rather than a peptide by the strict modern definition, but the history of insulin set the stage for the peptide research that followed.
In the 1940s and 1950s, Frederick Sanger sequenced insulin and showed for the first time that a peptide had a defined primary structure of amino acids in a specific order. This was a critical insight. Before Sanger, it was not certain whether proteins and peptides had defined sequences at all. After Sanger, it was clear that they did, and the question became how to synthesize them. The 1953 publication of the insulin sequence and the 1955 sequencing of oxytocin and vasopressin by Vincent du Vigneaud were among the early landmarks. Du Vigneaud also chemically synthesized oxytocin, demonstrating that a biologically active peptide could be made from scratch in the laboratory.
The next great advance came in the 1960s. Bruce Merrifield, working at Rockefeller University, developed solid-phase peptide synthesis. In Merrifield's method, the growing peptide chain is anchored to an insoluble polymer bead, and amino acids are added one at a time through a sequence of chemical coupling and deprotection steps. After the full sequence is built, the peptide is cleaved from the resin and purified. Merrifield received the Nobel Prize in Chemistry in 1984 for this work. Solid-phase peptide synthesis is still the foundation of how research peptides are made today.
The 1970s and 1980s brought a steady expansion of the catalog of known bioactive peptides. Endorphins and enkephalins were discovered as endogenous opioid peptides. Growth hormone releasing hormone, somatostatin, and a long list of hypothalamic releasing peptides were identified and synthesized. Synthetic analogs of these natural peptides were designed in academic and industry laboratories, including the early melanocortin analogs that would later become research tools such as Melanotan I and Melanotan II.
The 1990s brought the discovery of peptides such as BPC-157, originally identified as a fragment of a protective protein found in human gastric juice. The 2000s and 2010s brought the development of long-acting peptide analogs through chemical modification, including lipidated peptides such as GLP-1 SM that resist enzymatic degradation. The 2020s have seen continued growth in cyclic peptide drug discovery and in peptide based research tools across many fields.
For a survey of the more recent literature on peptide chemistry and pharmacology, the American Chemical Society publications portal and the Journal of Biological Chemistry host a large body of primary research papers that cover both fundamental and applied questions in peptide science.
Peptide structure and chemistry
The basic chemical unit of every peptide is the amino acid. There are twenty standard proteinogenic amino acids, each with a central carbon that bears a hydrogen, an amino group, a carboxylic acid group, and a distinctive side chain. The side chain is what distinguishes alanine from glycine from tryptophan from arginine. Some side chains are small and nonpolar. Some are large and aromatic. Some are positively charged at physiological pH. Some are negatively charged. Some can form hydrogen bonds. Some can form disulfide bridges. The combinatorial possibilities are enormous.
When two amino acids react, the carboxylic acid group of one forms a peptide bond with the amino group of the other, releasing a water molecule. The peptide bond is planar and has partial double bond character because of resonance between the carbonyl carbon and the nitrogen. This planarity is a key feature of peptide structure because it constrains how the chain can fold.
The full structure of a peptide is conventionally described at four levels. The primary structure is the linear sequence of amino acids from the amino terminus to the carboxyl terminus. By convention, sequences are written and read N to C, so a tripeptide written as GHK has glycine at the amino terminus, histidine in the middle, and lysine at the carboxyl terminus. The primary structure is what determines everything else.
The secondary structure refers to local folding patterns. Alpha helices, beta strands, and beta turns are the classic secondary structure elements. Many short peptides do not have stable secondary structure in solution because they are too small to support cooperative folding, but some do. The propensity to form a helix or a turn can be predicted from the amino acid sequence and is influenced by side chain interactions, by hydrogen bonding to water, and by the chemical environment.
The tertiary structure refers to the three dimensional fold of the entire molecule. Larger peptides and small proteins can have well defined tertiary structures with hydrophobic cores and surface side chains. The quaternary structure refers to assemblies of multiple chains and is more relevant to proteins than to short peptides.
In addition to these structural levels, many research peptides include chemical modifications that change their stability or their pharmacology. N terminal acetylation and C terminal amidation are common. D amino acid substitutions can increase resistance to enzymatic degradation. Cyclization through disulfide bonds, lactam bridges, or head to tail closure can stabilize a particular conformation. Lipidation, the attachment of a fatty acid chain, increases plasma half life by promoting binding to circulating albumin. PEGylation, the attachment of a polyethylene glycol chain, has a similar effect. These modifications are part of the toolbox that medicinal chemists use to turn a short bioactive sequence into a stable, useful research peptide.
The companion article on peptide structure and synthesis goes deeper into the chemistry of peptide bonds and the techniques used to characterize peptide structure.
Related research: Peptide Structure and Synthesis: Research Fundamentals.
How research peptides are made
The dominant method for making research peptides is solid-phase peptide synthesis, often abbreviated as SPPS. In SPPS, the C terminal amino acid of the target sequence is attached to a polymer resin that is insoluble in the reaction solvent. The amino group of this first amino acid is initially protected by a removable chemical group, most commonly the fluorenylmethyloxycarbonyl group, abbreviated as Fmoc. The synthesis cycle then proceeds as follows.
First, the Fmoc protecting group is removed to expose a free amino group. Second, the next amino acid in the sequence, also Fmoc protected and with its side chain protected as needed, is activated and coupled to the free amino group. Third, the resin is washed to remove unreacted reagents and byproducts. Fourth, the cycle repeats. Each cycle adds one amino acid to the growing chain. For a fifteen residue peptide such as BPC-157, the synthesis involves fifteen coupling cycles. For a forty four residue peptide such as Tesamorelin, the synthesis involves forty four coupling cycles. After the full sequence is built, the peptide is cleaved from the resin, the side chain protecting groups are removed, and the crude peptide is ready for purification.
Purification is almost always done by reversed-phase high-performance liquid chromatography, abbreviated as RP HPLC. The crude peptide is loaded onto a column packed with silica beads coated with hydrophobic chains, typically C18. A gradient of an organic solvent such as acetonitrile, mixed with a small amount of an acidic modifier such as trifluoroacetic acid, is run through the column. Different peptides elute at different times depending on their hydrophobicity. The fractions containing the target peptide are collected, pooled, and lyophilized to a dry powder. RP HPLC is also the most common method for measuring the purity of the final product and for generating the chromatograms that appear on a certificate of analysis.
After purification, the peptide is characterized to confirm its identity and purity. Mass spectrometry is the most common identity check. Electrospray ionization mass spectrometry, often abbreviated as ESI MS, ionizes the peptide and measures its mass to charge ratio. The observed mass is compared to the theoretical mass calculated from the sequence. A match within a small tolerance confirms that the peptide has the expected molecular weight. For longer peptides, fragment ion analysis by tandem mass spectrometry can confirm the actual sequence. Other characterization techniques such as nuclear magnetic resonance spectroscopy, amino acid analysis, and Edman degradation are used in specific circumstances.
A reputable supplier of research peptides will provide a certificate of analysis that includes at least the HPLC purity, the mass spectrometry identity confirmation, and lot specific information. Midwest Peptide accompanies every product with a third-party COA so that researchers can verify the identity and purity of the material they are working with.
The companion article on peptide structure and synthesis describes SPPS, RP HPLC, and mass spectrometry in more detail, with attention to the practical considerations that matter when reading a COA.
Major classes of research peptides
The catalog of bioactive peptides is large, and there is no single classification scheme that fits every molecule. Researchers usually classify peptides by source, by function, or by structure, and these schemes often overlap.
By source, peptides can be naturally occurring or synthetic. Naturally occurring peptides are produced by living organisms and include hormones such as insulin, growth hormone releasing hormone, oxytocin, and vasopressin, neuropeptides such as substance P and the enkephalins, antimicrobial peptides such as defensins and cathelicidins, and peptides produced by digestion or proteolysis such as the BPC-157 sequence. Synthetic peptides are made in the laboratory and include both faithful replicas of natural sequences and designed analogs that incorporate non-natural amino acids or chemical modifications.
By function, peptides can be grouped into hormones, growth factors, neuromodulators, immune modulators, antimicrobials, signaling peptides, and many other categories. Peptide hormones such as Tesamorelin, a growth hormone releasing hormone analog, illustrate the use of peptides as research tools for studying endocrine signaling. Growth hormone secretagogues such as GHRP-2, GHRP-6, and Ipamorelin are other examples in the same broad area. Tissue repair peptides such as BPC-157 and TB-500 are studied in animal models of injury and recovery. Skin and pigmentation peptides such as Melanotan I and Melanotan II are studied as melanocortin receptor agonists. Cognitive and behavioral peptides such as Selank and Semax are studied in animal models of stress and learning. Mitochondrial peptides such as MOTS-c are studied for their effects on cellular metabolism.
By structure, peptides can be linear or cyclic. Linear peptides are the simplest form and include most of the molecules listed above. Cyclic peptides have at least one ring formed by a bond between two residues that are not adjacent in the linear sequence. The ring can be formed by a disulfide bridge between two cysteines, by a lactam bridge between a lysine side chain and an aspartate or glutamate side chain, by a head to tail bond between the N terminus and the C terminus, or by other chemistries. Cyclic peptides often have improved stability and improved binding affinity compared to their linear counterparts because the ring constrains the molecule into a particular conformation. Melanotan II is an example of a cyclic peptide. Many naturally occurring antimicrobial peptides and venom peptides are also cyclic.
The companion article on peptide classification goes through each of these schemes in detail, with examples of each category.
Related research: Peptide Classification: Types and Categories in Research.
Delivery routes in research models
Peptides are not pills in the way that small molecules are. Most peptides are not orally bioavailable because they are degraded by digestive enzymes and because they are too large and too polar to cross the intestinal epithelium efficiently. Research applications therefore use a variety of delivery routes that depend on the peptide and the question being asked.
Subcutaneous injection is the most common route for systemic peptide research in animal models. Subcutaneous injection delivers the peptide into the loose connective tissue beneath the skin, where it diffuses into local capillaries and reaches the systemic circulation over a period of minutes to hours. The slow absorption profile of subcutaneous injection is often desirable because it produces a more sustained exposure than intravenous injection.
Intramuscular injection delivers the peptide into a skeletal muscle, where it is absorbed into the bloodstream through the dense capillary network of muscle tissue. Absorption is generally faster than subcutaneous and slower than intravenous. Intramuscular injection is sometimes used in research models when local delivery to a tissue near the muscle is desired or when a slightly faster onset is needed.
Intravenous injection delivers the peptide directly into the bloodstream and provides one hundred percent bioavailability by definition. Intravenous injection is used in pharmacokinetic studies because it provides a clean reference for comparison with other routes, and in studies where rapid onset is important. The disadvantage is that the peak concentration after intravenous injection is much higher than after subcutaneous or intramuscular injection, which can produce different effects in some experiments.
Oral delivery is generally a poor route for peptides because of digestive enzymes and the intestinal barrier. There are exceptions. Some peptides have unusual stability and can be absorbed in functional amounts after oral administration. BPC-157 is one example that has been studied with oral delivery in rodent research. There are also formulation strategies that can improve oral bioavailability, including enteric coatings, permeation enhancers, and conjugation to absorption enhancing carriers. The oral peptide therapeutics field has grown considerably in the last decade.
Intranasal delivery uses the rich vasculature and the relatively large surface area of the nasal mucosa to absorb peptides into the systemic circulation. It is also of interest for direct nose to brain delivery because of the olfactory and trigeminal nerve pathways that bypass the blood brain barrier. Intranasal delivery has been used in research with peptides such as Selank, Semax, and others.
Topical delivery, the application of peptides directly to the skin, is used in dermatological research. GHK-Cu has been studied with topical delivery in animal models of wound healing.
The companion article on peptide delivery routes goes through each of these routes in detail, with attention to the bioavailability, the stability considerations, and the research applications of each.
Related research: Peptide Delivery Routes in Research: Administration Methods.
Stability and storage
Peptides are generally less stable than small molecule drugs. They can be degraded by proteolytic enzymes, by oxidation of methionine and cysteine residues, by deamidation of asparagine and glutamine, by aggregation, and by hydrolysis of certain peptide bonds. The chemical stability of a peptide depends on its sequence, on its formulation, and on the storage conditions.
Most research peptides are supplied as a dry lyophilized powder, which is more stable than the same peptide in solution. The lyophilized form can typically be stored at minus twenty degrees Celsius for extended periods without significant degradation. Some peptides require minus eighty degrees Celsius for long term storage. Once a peptide is dissolved in a buffer or other solvent, its stability is generally limited and the solution should be stored cold and used within a defined time window.
Lyophilization, also called freeze drying, is the process used to convert a peptide solution into a stable dry powder. The peptide is first dissolved in a buffer that contains stabilizing additives such as mannitol or trehalose, then frozen, then dried under vacuum. The result is a porous cake that can be reconstituted with a defined volume of solvent at the time of use.
Researchers should refer to product literature and the COA for storage and handling instructions for each specific peptide. Midwest Peptide products are accompanied by COAs that include lot specific information, and customer support is available to answer technical questions about handling research peptides.
Research applications
Peptides are used as research tools across an enormous range of biological disciplines. The following is a partial map of where peptides show up in preclinical research.
In biochemistry, peptides are used as substrates and inhibitors of enzymes. A short peptide that contains the recognition sequence of a protease can be used as a substrate to measure protease activity. A longer peptide that mimics the natural substrate but cannot be cleaved can be used as a competitive inhibitor. Peptide based enzyme assays are widely used in basic research and in drug discovery screening.
In cell biology, peptides are used as receptor agonists and antagonists. A receptor that responds to a particular peptide hormone can be activated in cell culture by adding the peptide to the medium and the downstream signaling can be tracked. Peptide based activation is often more selective than small molecule activation, which makes peptides useful for studying specific receptor subtypes.
In immunology, peptides are used as antigens for raising antibodies, as epitopes for studying T cell responses, and as components of synthetic vaccine candidates in research models. The major histocompatibility complex molecules that present antigens to T cells bind short peptides, typically eight to fifteen residues long, and the field of peptide major histocompatibility complex research is large.
In neuroscience, peptides are used as research tools for studying neurotransmission, learning, memory, stress, and behavior in rodent models. Neuropeptides such as substance P, oxytocin, and vasopressin are studied as endogenous signaling molecules. Synthetic neuropeptides such as Selank and Semax are studied in research models that explore stress, anxiety, and learning.
In endocrinology, peptides are used as research tools for studying hormone action. Growth hormone releasing peptides, growth hormone releasing hormone analogs, and growth hormone secretagogues are all used as research tools to probe the somatotropic axis. Glucagon like peptide receptor agonists are used as research tools to probe metabolic signaling.
In tissue repair research, peptides such as BPC-157, TB-500, and GHK-Cu are studied in animal models of tendon, ligament, skin, gut, and other tissue injuries. The combined product KLOW brings several of these peptides into a single research formulation.
In dermal research, peptides are used as topical research compounds in animal models of wound healing, photoaging, and pigmentation. GHK-Cu is one of the most studied peptides in this area.
In metabolism research, peptides such as MOTS-c are studied for their effects on insulin sensitivity, mitochondrial function, and energy expenditure in rodent models. Peptide receptor agonists with longer half lives are studied in models of obesity and metabolic disease.
The companion article on peptide research applications goes deeper into each of these areas with examples and citations.
Related research: Peptide Research Applications: Preclinical Models.
Regulatory framework: research use only
The peptides described in this guide are research compounds. They are not approved drugs and they are not nutritional supplements. They are sold for in vitro studies, for cell culture experiments, and for animal model research. They are not for human consumption and they are not for clinical use.
The research use only designation, often abbreviated as RUO, is a category that applies to many laboratory reagents. Research peptides in this category are intended for use by qualified researchers who understand the limitations and the responsibilities that come with working with biologically active compounds. RUO products are not intended to diagnose, treat, cure, or prevent any disease in humans, and any health claims associated with them are inappropriate.
Researchers who work with peptides should follow the institutional policies of their laboratory, including any institutional animal care and use committee approvals required for animal research, any biosafety committee approvals required for work with biologically active compounds, and any local regulations that apply to the storage, handling, and disposal of research chemicals. Midwest Peptide supplies products to researchers under this framework and does not provide health, dosing, or therapeutic information.
Methodology Considerations for Peptide Research
A reliable peptide study depends on careful methodology across multiple dimensions.
Reconstitution and storage
- Reconstitute lyophilized peptide in sterile bacteriostatic water
- Aliquot to minimize freeze-thaw cycles
- Store reconstituted peptide refrigerated, used within validated time frames
- Document reconstitution date, concentration, and aliquot history
- Light protection for sensitive peptides
- pH considerations for stability
Dose selection
- Reference established preclinical dose ranges from the literature
- Consider species-specific PK when extrapolating
- Plan dose-response designs rather than single-dose comparisons
- Pre-specify primary biomarker endpoints
- Document dosing rationale clearly
Endpoint sampling
- Match sampling timing to expected biomarker timescale
- Multiple baseline samples for individual variability
- Standardized tissue collection protocols
- Validated assay platforms
- Pre-specified primary biomarker
- Consistent sample handling across timepoints
Quality control
- Verify Certificate of Analysis with each lot
- Document peptide source, lot number, and purity
- Lot-to-lot consistency assessment
- Cross-batch validation where feasible
Reporting Standards for Peptide Research
Reproducibility in peptide research requires structured reporting.
Recommended reporting elements
- Peptide source, lot number, and purity documentation
- Reconstitution protocol and storage history
- Dose, dosing route, and dosing schedule
- Research model species, age, sex, and baseline characteristics
- Biomarker timepoints and assay platform
- Statistical analysis plan
- Pre-specified primary and secondary endpoints
- Documentation of any deviations from protocol
Common pitfalls to avoid
- Single-timepoint biomarker readings without baseline anchoring
- Mixing peptide lots without documentation
- Inadequate sample size for population-level variability
- Failing to pre-specify primary endpoints
- Insufficient washout in crossover designs
- Conflating cell-based and whole-animal endpoints
Why structured reporting matters
- Cross-study comparison
- Reproducibility across labs
- Methodology development
- Transparency for peer review
Cross-Cluster Connections
Peptide research connects across the entire peptide research catalog.
Major peptide research clusters
- Tissue repair: BPC-157, TB-500, GHK-Cu, KLOW, GLOW
- GH-axis: Tesamorelin, CJC-1295/Ipamorelin, sermorelin
- Incretin biology: GLP-1 SM, GLP-2 TZ, GLP-3 RT, cagrilintide
- Melanocortin biology: Melanotan I, Melanotan II
- Mitochondrial biology: MOTS-c, NAD+, SS-31
- Neuropeptides: Selank, Semax, DSIP, VIP
- Antioxidant/dermal: Glutathione, GHK-Cu
- Multi-peptide blends: KLOW, GLOW, Tesa/Ipa, CJC/Ipa
Why cross-cluster reading helps
- Distinguishes class-specific effects from peptide-specific effects
- Provides framework for comparing receptor systems
- Helps identify shared methodology
- Supports comparative research design
Specific cross-cluster comparisons
| Cluster pair |
Comparative research questions |
| Tissue repair vs GH-axis |
Different mechanisms, overlapping body composition endpoints |
| Incretin vs amylin |
Different receptors, complementary satiety biology |
| Melanocortin vs incretin |
Different receptors, body weight overlap |
| Mitochondrial vs incretin |
Different mechanisms, metabolic infrastructure |
| Neuropeptides vs tissue repair |
Different mechanisms, anti-inflammatory overlap |
Related research: Peptide Research Design: In Vivo Study Fundamentals.
Common Mistakes in Peptide Research
Researchers can avoid several common pitfalls.
Methodology mistakes
- Single-timepoint biomarker readings without baseline anchoring
- Inadequate documentation of peptide source and reconstitution
- Mixing peptide lots without lot-level documentation
- Failing to pre-specify primary endpoints
- Inadequate sample size for population-level variability
Interpretation mistakes
- Conflating short-term gene expression with long-term tissue response
- Treating peptides with similar names but different chemistry as interchangeable
- Ignoring receptor desensitization in long-duration dosing
- Over-interpreting cell-based studies for whole-animal endpoints
- Translating preclinical findings prematurely to human contexts
Reporting mistakes
- Inadequate description of dosing schedule
- Missing baseline characterization
- Incomplete statistical analysis pre-specification
- Inconsistent units or timing conventions
How to avoid these mistakes
- Use validated assay platforms
- Document peptide source and lot information
- Pre-specify primary endpoints and analysis plans
- Match research design to PK characteristics
- Include appropriate vehicle controls
- Pre-register study protocols where feasible
- Deposit raw data in open repositories where feasible
- Use consistent units and timing conventions
Frequently Asked Research Questions
- High specificity for biological targets
- Selective receptor activation possible
- Defined chemistry enables reproducible research
- Wide range of mechanisms accessible
